Fiona LNG IUS
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Intrauterine
-
Intended Duration:
- Long-Acting
- Development Stage: Phase IV
- Developer(s)/researcher(s): Meril Life Science Private Ltd
Details
- API: Levonorgestrel
- Target: Progesterone Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Regimen: 1 Insertion/5 Years
- MPT: Not Potential MPT
- Promising Attributes: Fiona may be a more affordable 52mg hormonal IUD option at comparable efficacy and tolerance to globally-available HIUDs
Product Status
Recent Ph IV Clinical Research
History
Fiona LNG IUS has Indian regulatory approval, and has pursued post-approval clinical research to meet SRA standards.